Oaktree Capital Management »

Haemonetics shares owned by Oaktree Capital Management

Quarter-by-quarter ownership of Haemonetics shares owned by Oaktree Capital Management from 13F filings

Historical chart of Oaktree Capital Management investment in Haemonetics

Tip: Access up to 7 years of quarterly data

All positions including Haemonetics held by Oaktree Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Haemonetics by Oaktree Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.1M 6.6M 0.93
2024-03-31 $7.8M 8.4M 0.92
2023-12-31 $14M 15M 0.90
2023-09-30 $17M 19M 0.87
2023-06-30 $22M 26M 0.86
2023-03-31 $21M 25M 0.85
2022-12-31 $18M 22M 0.83
2022-09-30 $20M 25M 0.80
2022-06-30 $13M 17M 0.79
2022-03-31 $18M 22M 0.84

More positions owned by Oaktree Capital Management

Torm Common Stock (TRMD)
Chesapeake Energy Corp Common Stock (CHK)
Garrett Motion Common Stock (GTX)
Sitio Royalties Corp Common Stock (STR)
State Street Corp Etf Put Option (SPY)
Infinera Corp Common Stock (INFN)
Anglogold Ashanti Common Stock (AU)
Liberty Global Common Stock Call Option (LBTYA)
Star Bulk Carriers Corp Common Stock (SBLK)
Sunopta Common Stock (STKL)
Talen Energy Corp Common Stock (TLN)
Freeport-mcmoran Common Stock (FCX)
Runway Growth Finance Corp Common Stock (RWAY)
Vista Energy Sab De Cv Common Stock (VIST)
California Resources Corp Common Stock (CRC)

View all positions for Oaktree Capital Management

Top funds holding Haemonetics

Tenor Capital Management
Franklin Resources
MacKay Shields
Aviva
Osterweis Capital Management
Readystate Asset Management
Braidwell
Wells Fargo & Company
Lazard Asset Management
Oaktree Capital Management
State Street Corporation
Kohlberg Kravis Roberts & Co
SSI Investment Management
Bnp Paribas Investment Partners
BlackRock

View all funds holding Haemonetics